Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Advanced Malignant Solid Neoplasm × pamiparib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Ovarian Neoplasms 2 Glioblastoma 2 Glioma 1 Advanced Malignant Solid Neoplasm 1

Interventions

veliparib 1 pamiparib 1 dinaciclib 1 cabozantinib 1 Pharmacogenomic Variants 1 Patient Comfort 1 Palliative Care 1 Paclitaxel 1 Mindfulness-Based Stress Reduction 1 Mindfulness 1 Interviews as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05038839 2025-11-20

Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Active not recruiting

Other solid neoplasm

Advanced Malignant Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡